Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack ...

Just in time for allergy season, a recent FDA warning describes a new side effect for those who take Zyrtec or Xyzal ...

Shares of Bristol Myers BMY have lost 20.7% in the past three months compared with the industry ’s decline of 9.6%. The stock ...

Bristol-Myers Squibb's financial position improved, it raised both its EPS guidance and revenue expectations, and Opdivo's ...

However, a new programme of research in placebo studies indicates that it may be possible to harness placebo effects in clinical practice via ethical, non-deceptively prescribed ‘open label placebos’ ...

The label for diabetes treatment Ozempic, popularized by its use as a weight loss drug, will now list blocked intestines as a potential side effect. Two other similar drugs, Wegovy and Mounjaro, ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy from the FDA. If drugmakers want healthier people to have access to the ...

“The FDA label prohibits using the blood result alone to make — or to rule out — an AD diagnosis. It must be combined with your symptoms, history and a formal cognitive exam,” Moghekar sai ...

dThe Center for Medicine in the Media, Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA eDepartment of Population Medicine, Harvard ...

The FDA is prep­ping to rene­go­ti­ate its multi­bil­lion-dol­lar, quin­quen­ni­al user fee agree­ments with the drug in­dus­try lat­er this sum­mer, and a new deputy com­mis­sion ...

The test is for older Americans already exhibiting signs of Alzheimer's. The Food and Drug Administration (FDA) cleared the first blood test on Friday to help diagnose Alzheimer's disease.